Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.
about
Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine developmentA novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent modelsCharacterization of the structure and immunostimulatory activity of a vaccine adjuvant, de-O-acylated lipooligosaccharideA randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.Antigen distribution of TMUV and GPV are coincident with the expression profiles of CD8α-positive cells and goose IFNγ.Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8+ T Cell differentiation.Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2.Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology.A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral ImmunityInflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells.Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation.Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6.Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.IRF3 deficiency impacts granzyme B expression and maintenance of memory T cell function in response to viral infection.Caspase-1 Dependent IL-1β Secretion and Antigen-Specific T-Cell Activation by the Novel Adjuvant, PCEP.Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccinesTLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivoLeishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination.In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer.Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccines.Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.Significant role for IRF3 in both T cell and APC effector functions during T cell responses.Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.Adjuvanticity and toxicity of cobalt oxide nanoparticles as an alternative vaccine adjuvant.Old and new adjuvants.Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections.IL-6 production by dendritic cells is dispensable for CD8+ memory T-cell generation.Mechanism of immunopotentiation and safety of aluminum adjuvants.The influence of adjuvant on UreB protection against Helicobacter pylori through the diversity of CD4+ T-cell epitope repertoire.
P2860
Q21284959-5B29F3DF-6682-40A1-A9C6-85833C84A42FQ27312129-30E64728-CF45-4D79-82EB-14D9210580E7Q28538989-C5F92D92-30E8-4C38-AF13-592A78364CDEQ30278070-51294DAC-0811-499D-A8DB-BDB99332AC2CQ30387743-577AD526-FB35-4EC3-924C-6F4907EC3B1EQ30429719-DBC33AD9-0B3F-4C4D-8CC7-3F46BBBF45B5Q33774747-398E69A6-373E-4E11-A421-A873CD159297Q33807405-5D6F4CCC-CE87-4254-B628-644BF58F894EQ33994533-FD67856E-CA70-4726-9CE9-8E2A26AE5DB5Q34370741-99F49C94-70D1-4BCB-BEF3-D58F0C55EFFCQ34520389-DB432968-9CC7-4EC0-BBE9-4276E84D7B3BQ35106552-1347DDB0-6A90-4DC0-BA3B-81795E2E37DEQ35523289-4B7F492A-70A8-42A0-A43F-49C936F01B53Q35595880-82E06C7F-4B8A-4E0F-9D34-7A5DF428F3B9Q35772241-41C12566-63B5-41DA-AD89-C8DB69535858Q35776074-B39F8CE3-6F0B-4E88-A35F-FFE9DF32DF4DQ35826657-5BC04789-287E-4DBC-A29D-A80D9BB8DCE5Q35886450-EB42ECF7-5883-4F9F-8C0C-39B61AA228F1Q36220691-978647BF-C3D0-4BBC-93D3-9EB554DF6D23Q36350923-F6992FE1-4928-45C4-A95B-7B4E777EBFC9Q36452968-18C68BAE-90D3-45AF-B16E-C071C7F65CFCQ36680084-C8301FAF-E163-41B0-914E-22384A2B8333Q36738797-3B6C9C83-0D87-4E73-A914-3D278D3EB9F6Q37001755-14A16640-D64F-4708-86B2-037773BE76E3Q37078963-7CCE0EFB-B503-46C2-BD1F-FA102D16C072Q37371036-12D543CA-C2A6-40B7-9D9E-BFDBC4564315Q37545048-FF4597D3-5272-480E-8F1E-E306120DAF7CQ37563638-7CEF832C-0A01-49E9-AF9C-5CE5027E59CFQ37611798-83F3AA65-BDE2-4B8F-B9D5-226D371E96E7Q37981769-44409F0C-0591-44E3-B215-4281521FCCC3Q38261273-26C2FBAE-B6E8-4AD6-929B-3F6D4AAEA344Q38453147-8A8D9E13-4300-462B-82FC-4A20370F1CFFQ38745489-FB85ECB1-F227-494A-BF5B-7FCCBEF8ACA1Q39049093-99BFE1BC-E150-40EF-9D06-22649B787B6AQ39311895-CA15FB3C-28F2-48E2-86E1-4972739DB91FQ39451745-9F84848B-8AF4-4310-8B90-3D69916E5F21Q40245353-57AF22F4-AA30-4D0A-AA88-6391777E1F8EQ41482202-E9F88791-6F78-49E3-82FB-8DC02C90A523Q42036323-F8147110-4F0C-4F96-85A8-AE810787840BQ42366604-23E29BF0-EA75-4E18-831C-01C226B3424A
P2860
Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@ast
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@en
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@nl
type
label
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@ast
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@en
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@nl
prefLabel
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@ast
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@en
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@nl
P2093
P2860
P356
P1476
Vaccine adjuvants aluminum and ...... cytotoxic memory CD8 T cells.
@en
P2093
Alexandria David
Amy S McKee
Jieru Wang
Megan K L MacLeod
Robert Mason
P2860
P304
P356
10.1073/PNAS.1104588108
P407
P577
2011-04-25T00:00:00Z